• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab therapy for refractory autoimmune thrombocytopenia in patients with systemic lupus erythematosus.

作者信息

Atay Didem, Oztürk Gülyüz, Anak Sema, Devecioğlu Omer, Unüvar Ayşegül, Karakaş Zeynep, Ağaoğlu Leyla

机构信息

Okmeydani Education and Research Hospital, Department of Pediatric Hematology and Oncology, İstanbul, Turkey.

Istanbul University, Istanbul School of Medicine, Department of Pediatric Hematology, Oncology, BMT, İstanbul, Turkey.

出版信息

Turk J Haematol. 2012 Mar;29(1):92-3. doi: 10.5505/tjh.2012.26539. Epub 2012 Mar 5.

DOI:10.5505/tjh.2012.26539
PMID:24744634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3986779/
Abstract
摘要

相似文献

1
Rituximab therapy for refractory autoimmune thrombocytopenia in patients with systemic lupus erythematosus.利妥昔单抗治疗系统性红斑狼疮患者难治性自身免疫性血小板减少症
Turk J Haematol. 2012 Mar;29(1):92-3. doi: 10.5505/tjh.2012.26539. Epub 2012 Mar 5.
2
Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.低剂量利妥昔单抗治疗系统性红斑狼疮所致激素耐药性血小板减少症。
Rheumatol Int. 2020 Oct;40(10):1717-1724. doi: 10.1007/s00296-020-04668-4. Epub 2020 Aug 14.
3
Rituximab induced acute thrombocytopenia in a patient with systemic lupus erythematosus: a case report.利妥昔单抗诱导系统性红斑狼疮患者发生急性血小板减少症：病例报告。
J Med Case Rep. 2021 Jul 8;15(1):339. doi: 10.1186/s13256-021-02950-y.
4
B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.儿童系统性红斑狼疮中自身免疫性血小板减少症和自身免疫性溶血性贫血的B细胞清除疗法
Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15.
5
Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.利妥昔单抗治疗对儿童期起病的系统性红斑狼疮难治性血细胞减少症有快速且持久的反应。
Lupus. 2015 Aug;24(9):966-72. doi: 10.1177/0961203315578764. Epub 2015 Mar 24.
6
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.抗 CD20 治疗难治性系统性红斑狼疮患者：52 例西班牙裔患者的纵向分析。
Lupus. 2010 Feb;19(2):213-9. doi: 10.1177/0961203309351541. Epub 2009 Dec 4.
7
[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].利妥昔单抗治疗系统性红斑狼疮相关免疫性血小板减少症
Ann Dermatol Venereol. 2006 Jan;133(1):53-5. doi: 10.1016/s0151-9638(06)70845-6.
8
Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.利妥昔单抗成功治疗与系统性红斑狼疮相关的难治性噬血细胞性淋巴组织细胞增生症和自身免疫性溶血性贫血。
Mod Rheumatol. 2014 Sep;24(5):855-7. doi: 10.3109/14397595.2013.874740. Epub 2014 Feb 11.
9
Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.达那唑用于治疗系统性红斑狼疮中的难治性自身免疫性血小板减少症。
Ann Intern Med. 1988 May;108(5):703-6. doi: 10.7326/0003-4819-108-5-703.
10
Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.抗CD20抗体（利妥昔单抗）成功治疗系统性红斑狼疮患者的无巨核细胞性血小板减少症
Lupus. 2008 Mar;17(3):210-4. doi: 10.1177/0961203307086032.

引用本文的文献

1
The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study.FcγRIIIA基因多态性对弥漫性大B细胞非霍奇金淋巴瘤治疗的影响：一项多中心前瞻性观察研究。
Turk J Haematol. 2015 Jun;32(2):152-7. doi: 10.4274/tjh.2013.0367.

本文引用的文献

1
B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.儿童系统性红斑狼疮中自身免疫性血小板减少症和自身免疫性溶血性贫血的B细胞清除疗法
Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15.
2
Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.利妥昔单抗治疗慢性或难治性血液系统自身免疫性血细胞减少症儿科患者后的安全性、疗效及免疫重建
Pediatr Blood Cancer. 2008 Apr;50(4):822-5. doi: 10.1002/pbc.21264.
3
Rituximab therapy for childhood-onset systemic lupus erythematosus.利妥昔单抗治疗儿童期起病的系统性红斑狼疮
J Pediatr. 2006 May;148(5):623-627. doi: 10.1016/j.jpeds.2006.01.041.
4
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.利妥昔单抗治疗儿童及青少年慢性免疫性血小板减少性紫癜的前瞻性1/2期研究。
Blood. 2006 Apr 1;107(7):2639-42. doi: 10.1182/blood-2005-08-3518. Epub 2005 Dec 13.
5
Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.利妥昔单抗用于难治性伊文氏综合征及其他免疫介导的血液系统疾病。
Am J Hematol. 2004 Nov;77(3):303-10. doi: 10.1002/ajh.20180.
6
Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.抗B细胞疗法（利妥昔单抗）在自身免疫性疾病治疗中的应用。
Curr Opin Pharmacol. 2004 Aug;4(4):398-402. doi: 10.1016/j.coph.2004.03.006.
7
Monoclonal antibodies in the treatment of autoimmune cytopenias.单克隆抗体在自身免疫性血细胞减少症治疗中的应用
Eur J Haematol. 2004 Feb;72(2):79-88. doi: 10.1046/j.0902-4441.2003.00196.x.
8
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.利妥昔单抗治疗儿童难治性自身免疫性溶血性贫血
Blood. 2003 May 15;101(10):3857-61. doi: 10.1182/blood-2002-11-3547. Epub 2003 Jan 16.